Medivation

Why does UK biotech struggle to generate leaders?

https://pharmaphorum.com/views-and-analysis/uk-biotech-struggle-generate-leaders/

Takeda earmarks $15 billion for M&A – reports

https://pharmaphorum.com/news/takeda-earmarks-15-billion-ma/

Medivation deal could spark biotech M&A

https://pharmaphorum.com/news/medivation-deal-spark-biotech-ma/

Pfizer confirms $14bn Medivation merger

https://pharmaphorum.com/news/pfizer-confirms-14bn-medivation-merger/

Merck, Pfizer and Gilead all interested in Medivation buy-out

https://pharmaphorum.com/news/merck-pfizer-gilead-interested-medivation-buy-2/

Medivation cancer drug ‘best in class’ – CEO

https://pharmaphorum.com/news/medivation-has/

Medivation in merger talks with Sanofi and others

https://pharmaphorum.com/news/medivation-takeover-talks-sanofi-others/

Sanofi pushes on with Medivation takeover attempt

https://pharmaphorum.com/news/sanofi-pushes-medivation-takeover-attempt/

Medivation hits back at Sanofi’s boardroom coup attempt

https://pharmaphorum.com/news/medivation-hits-back-at-sanofis-boardroom-coup-attempt/

Close in 10 seconds

Pharmaphorum.com

Search